They opposed REC sales in Arizona.
Here’s your daily dose of pot news from the newsletter WeedWeek.
Several former executives of Insys Therapeutics, which sells the powerful opiate fentanyl, were arrested accused of “ bribing doctors, defrauding insurance companies, and fueling America’s opioid addiction crisis.” Insys contributed to successfully defeat Arizona’s November REC vote.
Bloomberg suggests there’s a Canadian pot-stock bubble.
Legalization in more states could depress California’s export market. And in another interesting piece by Madison Margolin, California’s “extract artisans” now have some legal protections from meth-lab laws.
Vice dives into regulatory tech which it calls the “ cannabis surveillance state.”
Home grow system Leaf raised $2M.
Commercial landlords in northern California prepare for legalization.
The Denver Post’s Cannabist won most influential media source at the cannabis business awards.
In an effort to reduce opioid use, Oregon wants opioid patients monitored for marijuana use. The health agency view on marijuana vis a vis opioid use is unclear.
The world’s first clinical trial to test MED for chemotherapy patients is beginning in Australia.
A device developed by Israeli start-up distributes “ nano-droplets” of CBD as a nutraceutical to relieve inflammation and pain is on sale in the U.S. KKTV looked at the cannabis research happening at Colorado State-Pueblo.
The U.S. is lagging Israel and other countries in cannabis research.
The Washington [state]CannaBusiness Association is starting a fund to support MED access for the needy.